Clinical Trials
2 trialsNCT04549207 2026-04-07
Comparing Continuation or De-escalation of Bone Modifying Agents (BMA) in Patients Treated for Over 2 Years for Bone Metastases From Either Breast or Castration-resistant Prostate Cancer
Ottawa Hospital Research Institute
Phase 4 Active not recruiting
NCT03664687 2026-02-09
REaCT-ZOL
Ottawa Hospital Research Institute
Phase 4 Completed